Association between antibiotics and adverse oncological outcomes in patients receiving targeted or immune-based therapy for hepatocellular carcinoma

BACKGROUND & AIMS: Immune checkpoint inhibitors (ICIs) alone or in combination with other ICIs or vascular endothelial growth factor pathway inhibitors are therapeutic options in unresectable/metastatic hepatocellular carcinoma (HCC). Whether antibiotic (ATB) exposure affects outcome remains unc...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinato, David J., Li, Xiaoxue, Mishra-Kalyani, Pallavi, D’Alessio, Antonio, Fulgenzi, Claudia A.M., Scheiner, Bernhard, Pinter, Matthias, Wei, Guo, Schneider, Julie, Rivera, Donna R., Pazdur, Richard, Theoret, Marc R., Casak, Sandra, Lemery, Steven, Fashoyin-Aje, Lola, Cortellini, Alessio, Pelosof, Lorraine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183666/
https://www.ncbi.nlm.nih.gov/pubmed/37197442
http://dx.doi.org/10.1016/j.jhepr.2023.100747

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183666/
https://www.ncbi.nlm.nih.gov/pubmed/37197442
http://dx.doi.org/10.1016/j.jhepr.2023.100747

Ejemplares similares